Department of Breast and Thyroid Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of General Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ann Palliat Med. 2021 Mar;10(3):2824-2831. doi: 10.21037/apm-20-1972. Epub 2021 Feb 7.
Granulomatous lobular mastitis (GLM) is a benign chronic inflammatory breast disease with indecisive etiology and easy recurrence, and seriously affects physical and mental health of women. This study aims to discover the factors associated with the recurrence of GLM and provide some new thoughts for the treatment.
We retrospectively collected clinical data of GLM patients from January 2010 to June 2019. Patients were divided into no recurrence group (group A) and recurrence group (group B). Demographic data and clinical features were compared in two groups.
There were 103 (79.23%) patients in group A and 27 (20.77%) in group B. In univariate analysis, body mass index (BMI), the difference of prolactin (PRL) level before and after treatment and follicle-stimulating hormone (FSH)/luteinizing hormone (LH) were associated with the recurrence of GLM. Moreover, the difference of PRL level before and after treatment was the independent risk factor of recurrence and patients presenting with higher PRL after treatment than before treatment had a higher risk of recurrence [odds ratio (OR) 21.405, 95% confidence interval (CI): 1.702-269.233, P=0.018].
Obesity or overweight and FSH/LH had association with GLM recurrence, and the difference of PRL level before and after treatment is the independent risk factor of recurrence. Clinical examination of hormone levels especially the PRL level should not be ignored during and even after the treatment of GLM.
肉芽肿性小叶性乳腺炎(GLM)是一种良性的慢性炎症性乳腺疾病,病因不明确,易复发,严重影响女性身心健康。本研究旨在发现与 GLM 复发相关的因素,为治疗提供新的思路。
回顾性收集 2010 年 1 月至 2019 年 6 月 GLM 患者的临床资料。患者分为无复发组(A 组)和复发组(B 组)。比较两组患者的人口统计学资料和临床特征。
A 组 103 例(79.23%),B 组 27 例(20.77%)。单因素分析显示,体质量指数(BMI)、治疗前后催乳素(PRL)水平差值及卵泡刺激素(FSH)/黄体生成素(LH)与 GLM 的复发相关。而且,治疗前后 PRL 水平差值是 GLM 复发的独立危险因素,治疗后 PRL 水平高于治疗前的患者复发风险更高[比值比(OR)21.405,95%置信区间(CI):1.702-269.233,P=0.018]。
肥胖或超重及 FSH/LH 与 GLM 复发有关,治疗前后 PRL 水平差值是 GLM 复发的独立危险因素。在 GLM 的治疗期间甚至治疗后,临床检查激素水平,尤其是 PRL 水平不容忽视。